BIOCENTECH APS: Financial statements 2019
CVR: 25437470
Source: annual report 2019, Danish Business Authority
01/10/2018 – 30/09/2019
BIOCENTECH APS (CVR 25437470) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -5,000 and a net result of DKK -4,867 compared with DKK -6,705 the year before. Equity in the 2019 report amounted to DKK 23,502. The solvency ratio was 31.1%.
- Gross Profit
- DKK -5,000
- Profit/Loss
- DKK -4,867
- Equity
- DKK 23,502
- Total Assets
- DKK 75,639
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -5 t. | -5 t. | 24 t. | - |
| 2018 | - | -8 t. | -7 t. | 28 t. | - |
| 2017 | - | -5 t. | -3 t. | 35 t. | - |
| 2016 | - | -5 t. | -3 t. | 38 t. | - |
| 2015 | - | -5 t. | -2 t. | 41 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
BIOCENTECH APS has published its annual report for 2018. Gross profit came to DKK -7,680, and the net result was DKK -6,705.
About BIOCENTECH APS
BIOCENTECH APS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company is registered under the industry Fremstilling af andre maskiner til specielle formål i.a.n.. The management consists of Aleksander Nærvig. The company is owned by NÆRVIG GROUP ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -13,000 and a net result of DKK -14,669 compared with DKK -19,363 the year before. Equity in the 2025 report amounted to DKK -61,305.